Evidence
J Addict Med. 2023 Dec 1. doi: 10.1097/ADM.0000000000001251. Online ahead of print.
ABSTRACT
Persons with opioid use disorder (OUD) are receiving extended-release buprenorphine (ER-buprenorphine) for treatment of OUD. There are no clinical guidelines for management of patients with OUD on ER-buprenorphine experiencing acute or chronic pain. This case report describes 3 patient-involved, multidisciplinary approaches for pain management in various clinical scenarios, including a scheduled knee replacement, emergent surgery for an ischemic limb, and management of chronic pain from metastatic malignancy. These cases illustrate that adequate analgesia for patients who have received ER-buprenorphine is possible, and approaches can be individualized, with shared decision making between providers and patients addressing all barriers to optimize treatment outcomes. Options for acute pain management that can be considered include supplemental sublingual buprenorphine, nonopioid adjuncts, and short courses of full opioid agonists. Potential barriers that impact OUD and acute/chronic pain are provider bias, limited access to palliative care clinicians with addiction medicine training, and payor restrictions to adding sublingual buprenorphine for patients that are on ER-buprenorphine. Additional training for clinicians and other members of the health care team is recommended to improve patient-involved care of persons with OUD experiencing pain.
PMID:38039082 | DOI:10.1097/ADM.0000000000001251
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
🌐 90 Days
VR Related Evidence Matrix
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
- Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
- Buprenorphine Affects the Initiation and Severity of Interleukin Induced Acute Pancreatitis in Mice
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
- Oxytocin Modulation in Mindfulness-Based Pain Management for Chronic Pain
- The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial
- Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians
- Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
- An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report
- Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation
- Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
- Opioid use and risks in liver transplant candidates and recipients
- Access to Mental Health and Substance Use Treatment in Comprehensive Primary Care Plus
- Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach
- Opioid-Free Analgesia is Safe and Effective in Anterior Cervical Spine Surgery: A Randomized Controlled Trial
- Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
- Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes
- High-Dose Buprenorphine Initiation: A Scoping Review
- Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder
- Experiences and perspectives of adults on using opioids for pain management in the postoperative period: A scoping review
- Anatomo-physiological basis and applied techniques of electrical neuromodulation in chronic pain
- Chronic pain in pediatric patients: epidemiology, pathophysiology, and mitigation strategies
- Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
- Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022
- Patient perspectives on the unwanted effects of multidisciplinary pain management programmes: A qualitative study
- Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives
- A population-based time-series analysis of opioid agonist treatment dispensed during pregnancy
- Postoperative pain score does not correlate with injury severity in isolated tibial plateau fractures
- Postoperative pain score does not correlate with injury severity in isolated tibial plateau fractures
- Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults
- Appropriateness of behavioural scales in the monitoring of pain in the critically ill patient unable to self-report
- Levels of engagement among office-based opioid treatment (OBOT) patients with concurrent methamphetamine use
- Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
- Opioid-free anesthesia : Wrong track or meaningful exit from the era of opioid-based analgesia?
- Long-term opioid therapy dose patterns in United States patients
- 10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder
- Mechanisms of pain in aging and age-related conditions: focus on caregivers
- Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy
- Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy
- Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder
- Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment
- Application of an opioid use disorder cascade of care in a large public health system
- Pediatric chronic pain and exposure to bullying as perpetrator or victim
- Pediatric chronic pain and exposure to bullying as perpetrator or victim
- Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
- Anxiety, pain catastrophizing, and pain outcomes among older adults with chronic orofacial pain
- Emerging Trends in Opioid Use Disorder Management: A 6-Year Analysis of Emergency Department Visits, Buprenorphine Prescriptions, and Naloxone Distribution (2016-2021)
- Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial
- Recent developments and challenges in positron emission tomography imaging of gliosis in chronic neuropathic pain
- Comparison of Opioid Use Disorder Patients with and without Problematic Internet Use in Terms of Impulsivity and Attention Deficit Hyperactivity Disorder
- Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting
- Mimicking opioid analgesia in cortical pain circuits
- Tailored Yoga Intervention for Postlumbar Spine Surgical Pain Management: A Feasibility Study
- Two-year Opioid Prescription Trends in Local Sanitary Agency Naples 3 South, Campania Region, Italy. Descriptive Analyses and AI-based Translational Perspectives
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
- Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum
Evidence Blueprint
Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report
🌐 365 Days
VR Related Evidence Matrix
- Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments
- An Appraisal of Using Opioids in Patients with Opioid Use Disorder
- Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series
- ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
- Acute Pain Management for Patients Maintained on Sublingual Buprenorphine as Medication for Opioid Use Disorder
- Extended-release Buprenorphine Administered at Discharge in Hospitalized Persons With Opioid Use Disorder: A Case Series
- Characterizing Acute and Postsurgical Pain Management in Patients Receiving Buprenorphine or Buprenorphine/naloxone
- Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
- Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States
- Buprenorphine and Opioid Use Disorder Training: Graduate Nursing Curricula Recommendations
- Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
- Emergency Department Access to Buprenorphine for Opioid Use Disorder
- Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use
- Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine
- Kratom use disorder: case reports on successful treatment with home induction of buprenorphine-naloxone
- Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records
- Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial
- The Perceived Role of Withdrawal in Maintaining Opioid Addiction among Adults with Untreated Opioid Use Disorder: A Survey of Syringe Exchange Program Participants
- Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?
- The Analgesic Mismanagement of a Patient With Ehlers-Danlos Syndrome (Hypermobility Variant): A Case Report
- Hospital-based opioid treatment: Expanding and sustaining the model in Texas
- Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
- Reliability of urine drug testing among patients on buprenorphine transdermal patch
- Compassionate Care for People with Cancer and Opioid Use Disorder
- Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals
- Evidence on Buprenorphine Dose Limits: A Review
- Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
- Low-dose Induction of Buprenorphine in Pregnancy: A Case Series
- The association of medical providers' attitudes about naloxone and people with opioid use disorder and their self-reported "low-barrier" treatment practices
- Treatment of poppy seed tea misuse with buprenorphine in a telehealth practice: a case series
- Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention
- Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment
- Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic
- Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study
- Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA
- Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
- Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency
- Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
- The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews
- Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation
- Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs
- Framing Chronic Pain in U.S. News Coverage of the Opioid Epidemic (2012-2022)
- Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder
- Low Dose Buprenorphine Initiation: A Guide for the Inpatient Clinician
- Buprenorphine Affects the Initiation and Severity of Interleukin Induced Acute Pancreatitis in Mice
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review
- Identification of opioid use disorder using electronic health records: Beyond diagnostic codes
- Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report
- Survey of barriers and opportunities for prescribing buprenorphine for opioid use disorder in Alabama
- Case Series of Individuals Treated with Naltrexone during Pregnancy for Opioid and/or Alcohol Use Disorder
- Prescriptions for Buprenorphine in Michigan Following an Education Intervention
- Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder
- Buprenorphine Monoproduct for Buprenorphine/Naloxone Tolerability Problems: Navigating Stigma for Patient-centered Addiction Care without Guideline Support
- Adrenal Crisis Masked as Septic Shock in a Patient With Opioid Use Disorder on Buprenorphine
- Extended-release buprenorphine in pregnancy
- Severe tianeptine withdrawal symptoms managed with medications for opioid use disorder: a case report
- Collaborative Care Models to Improve Pain and Reduce Opioid Use in Primary Care: a Systematic Review
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review
- Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states
- Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
- Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
- Intersectional Risk and the Significant Gap in Care for Persons with Co-occurring Chronic Pain and Opioid Withdrawal
- Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut